DataBiologics
DataBiologics is a healthcare data platform that helps regenerative medicine providers and medical device companies collect patient-reported outcomes, benchmark against the largest US regenerative medicine registry (43,926+ cases, 314+ providers), and build real-world evidence via a SaaS subscription and device partnership model.
- Company typePrivate
- Founded2019
- HeadquartersCedar Knolls, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What DataBiologics does
DataBiologics, Inc. is a Delaware-incorporated, privately held healthcare data platform founded in 2019 by three regenerative medicine physicians (Drs. Chris Rogers, Jay Bowen, and the late Gerard Malanga) and headquartered in Mesa, Arizona. The company operates what it describes as the largest regenerative medicine outcomes registry in the United States, aggregating 43,926+ documented cases from 314+ providers across 40+ states, supported by 529,883+ completed patient surveys with a reported 73-75% average response rate against an industry baseline of 15-25%.
The platform provides automated patient-reported outcomes (PRO) collection with pre-loaded validated instruments (NPRS, KOOS JR, QuickDASH, and others), scheduled survey cadences at 1, 3, 6, and 12 months, real-time visualization dashboards, and benchmarking against the national registry. It is delivered through a HIPAA-, PIPEDA-, and GDPR-compliant infrastructure with SSO options (Google, Microsoft, GitHub, Apple OAuth) and supports both provider self-serve onboarding and a medical device partnership program (SPrint). Customer logos span major health systems (Emory Healthcare, OhioHealth, NYU Langone Langone), regenerative medicine clinics, medical device companies (notably SoftWave Tissue Regeneration Technologies), and medical education organizations (TOBI, IOF).
Revenue is generated primarily through SaaS subscriptions at $200/provider/month for the Professional tier (with unlimited patient enrollment), custom volume pricing for multi-provider clinics billed annually, a free Data Contributor tier (data contribution without insights), and enterprise partnerships with medical device companies for real-world evidence generation and sales enablement. The company also offers marketing solutions (practice performance reports, patient testimonial collection, competitive benchmarking). The go-to-market combines direct sales with personalized specialty-specific demos, self-serve signup through helix.databiologics.com, and channel partnerships, supported by conference presence at TOBI, RMOS, IOF MAX, and AAPMR. Notable partnerships include SoftWave Tissue Regeneration Technologies (flagship shockwave therapy outcomes program, expanded into the SoftWave Team initiative in January 2025), MD Hyperbaric (HBOT pilot, October 2024), and ARPA-H's Investor Catalyst Hub (spoke designation, December 2023). Leadership transitioned in late 2025 with Luke Malanga appointed CEO in December 2025 and Martin Cody joining as EVP of Sales in August 2025.
DataBiologics firmographics
Firmographics- Name
- DataBiologics
- Legal name
- DataBiologics, Inc.
- Website
- https://databiologics.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- DataBiologics is a healthcare data platform that helps regenerative medicine providers and medical device companies collect patient-reported outcomes, benchmark against the largest US regenerative medicine registry (43,926+ cases, 314+ providers), and build real-world evidence via a SaaS subscription and device partnership model.
- Ownership category
- akta.pro rank
DataBiologics industry classification
Industry- Product category
- Clinical Outcomes Analytics Software
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)
- akta.pro secondary industries
- eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
Keywords
Where DataBiologics is headquartered
LocationHeadquarters
- HQ city
- Cedar Knolls
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
DataBiologics business model
Business model- GTM type
- B2B
- Offering type
- Software
Revenue model
- Professional Tier Subscription: $200 per provider per month subscription with unlimited patient enrollment, automated surveys at 1, 3, 6 & 12 months, real-time outcomes dashboard, and benchmarking against the registry.
- Multi-Provider Clinic Pricing: Custom volume pricing for clinics with multiple providers including team dashboard views and dedicated onboarding. Annual plans with satisfaction guarantee.
- Medical Device Partnership (SPrint): Partnership programs for medical device companies to access provider network for evidence generation, sales enablement reports, and real-world evidence accumulation.
- Marketing Solutions: Evidence-based marketing tools including practice performance reports, patient testimonial collection, and competitive benchmarking dashboards.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Data Contributor - Free tier for practices contributing outcomes data |
| Per seat | Monthly | Professional - $200/provider/month with full platform access |
| Subscription | Annual | Multi-Provider Clinics - Custom pricing for volume deployments |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
DataBiologics product offering
Product offeringCore offering
DataBiologics operates a healthcare outcomes tracking platform that uses proprietary automation to collect patient-reported outcomes (PRO) data via automated SMS/email surveys and presents real-time visualization dashboards. The platform allows regenerative medicine providers to benchmark their treatment outcomes against the largest US regenerative medicine registry (314+ providers, 43,926+ cases), and offers a separate medical-device partnership program (SPrint) that supplies real-world evidence and sales-enablement reports to device companies.
Differentiator
Problem solved
Functional benefit
Products and services
- IMPACT Platform
- Helix Self-Serve Platform
Companies that use DataBiologics
Customer profileNamed customers15 records
Segments4 records
DataBiologics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
Feature8 records
DataBiologics partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered flagship, core and minor.
- SoftWave Tissue Regeneration TechnologiesflagshipLaunch of 'SoftWave Team' collaborative initiative enabling providers to contribute to and benefit from shared insights by tracking real-world data on shockwave therapy outcomes. SoftWave sponsors participation at no cost to providers. Includes exclusive dashboard showing SoftWave-specific trends across practices.
- MD HyperbariccorePilot study partnership evaluating impact of hyperbaric oxygen therapy (HBOT) on chronic conditions including inflammation and autoimmune diseases. DataBiologics provides software platform to collect and analyze real-world patient outcomes for the study.
- SoftWave Tissue Regeneration TechnologiesflagshipPartnership for SoftWave providers to track shockwave therapy outcomes on DataBiologics platform. Includes exclusive SoftWave Team dashboard compiling treatment data from all participating providers. John Warlick, CEO of SoftWave, stated partnership enables providers to validate patient outcomes and build evidence for shockwave therapy effectiveness.
- National Basketball Athletic Trainers Association (NBATA)minorDr. Steven Sampson of Orthohealing Center presented shockwave therapy outcomes data at NBA Combine for NBATA. Collaboration demonstrates effectiveness of treatments with elite athletes using DataBiologics registry outcomes.
- ARPA-H Investor Catalyst HubcoreSelected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H health innovation network. Partnership connects DataBiologics with a nationwide network working to accelerate transformative health solutions.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
DataBiologics competitors and assessment
Company assessmentEmerging players
- mPulse Mobile: Patient engagement and outcomes platform with automated SMS/email outreach for healthcare providers. Comparable automated messaging-driven patient data collection and provider SaaS GTM, though broader in use cases beyond regenerative medicine.
- Evidation: Real-world evidence platform aggregating patient-generated health data across conditions. Comparable as a modern RWE platform; serves life sciences and device companies for evidence generation — a similar end market to DataBiologics' device partnership channel.
- Medrio: EDC and eClinical platform for clinical trials and registries, with electronic patient-reported outcome (ePRO) capabilities. Comparable technology layer (ePRO + data capture) and serves medical device and biopharma customers, though focused more on regulated trials than observational registries.
Direct peers
- PatientIQ: Patient-reported outcomes platform for specialty care providers with national benchmarking — most direct functional overlap with DataBiologics, including automated PRO collection, dashboards, and registry benchmarking. Targets orthopedics and other specialties with similar provider GTM.
- ArborMetrix: Clinical performance analytics and outcomes registry platform serving specialty medical societies and provider groups. Comparable to DataBiologics in registry-based benchmarking and evidence generation for specialty care, including orthopedics and procedural specialties.
- Q-Centrix: Healthcare data abstraction, registry, and clinical quality outcomes company serving hospitals and health systems. Comparable in clinical registry operations, real-world data capture, and enterprise healthcare customer base, with broader reach across service lines.
- FIGmd: Specialty clinical data registry and analytics platform used by medical societies and practices. Strongly comparable on the registry, data aggregation, and MIPS/MACRA quality reporting layer adjacent to DataBiologics' outcomes benchmarking.
Regional players
- Outcomes Insights, Inc. Real-world evidence and clinical research services company supporting medical device and orthobiologics companies with registry and post-market evidence generation. Directly comparable use case (device RWE) to DataBiologics' SPrint medical device partnership channel.
Broad incumbents
- Health Catalyst: Large enterprise healthcare data and analytics platform with outcomes measurement and benchmarking capabilities. Not specialized in regenerative medicine but offers overlapping RWD/RWE functionality to large health systems, the same buyer segment DataBiologics targets.
- Veradigm (formerly Allscripts Practice Fusion) Outcomes/Registry partners: Large EHR and healthcare data vendor with outcomes and registry-adjacent offerings across ambulatory and specialty settings. Represents the broader incumbent layer DataBiologics must integrate or compete with for system-wide data workflows.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
DataBiologics social profiles
Digital presenceDataBiologics financial estimates
Financial estimateRevenue estimate
Valuation estimate
DataBiologics leadership team
Management profileNumber of profiles
DataBiologics funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DataBiologics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DataBiologics
What does DataBiologics do?
DataBiologics operates a healthcare outcomes tracking platform that uses proprietary automation to collect patient-reported outcomes (PRO) data via automated SMS/email surveys and presents real-time visualization dashboards. The platform allows regenerative medicine providers to benchmark their treatment outcomes against the largest US regenerative medicine registry (314+ providers, 43,926+ cases), and offers a separate medical-device partnership program (SPrint) that supplies real-world evidence and sales-enablement reports to device companies.
Is DataBiologics a public or private company?
DataBiologics is a private company. It is currently operating.
When was DataBiologics founded?
DataBiologics was founded in 2019. It employs 11 to 50 people.
Where is DataBiologics based?
DataBiologics is headquartered in Cedar Knolls, United States, in the North America region.
How does DataBiologics make money?
Four revenue lines are on record. Professional Tier Subscription is the primary driver. The others are multi-Provider Clinic Pricing, medical Device Partnership (SPrint) and marketing Solutions.
Who are DataBiologics's main competitors?
Emerging players on record are mPulse Mobile, Evidation and Medrio. Direct peers are PatientIQ, ArborMetrix, Q-Centrix and FIGmd. Outcomes Insights, Inc. is listed as a regional player. Broad incumbents are Health Catalyst and Veradigm (formerly Allscripts Practice Fusion) Outcomes/Registry partners.
Does DataBiologics have an API?
No public API is recorded for DataBiologics.
What industry is DataBiologics in?
DataBiologics's product category is Clinical Outcomes Analytics Software. Its primary akta.pro industry code is HLACAOAM, Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms, with a secondary code of HLACAOAB, eCOA/ePRO/eDiary & Patient-Facing Data Collection. Its NAICS code is 518 and its SIC code is 7372.